A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2009
10/07/2009	EP1874285B1 Complementary compositions to reduce blood glucose levels and treat diabetes
10/07/2009	EP1617216B1 Novel method of screening
10/07/2009	EP1509227B1 A buffered, liquid nicotine composition for pulmonary administration
10/07/2009	EP1505075B1 Antibody to human insulin-like growth factor
10/07/2009	EP1434791B1 Specific binding agents of human angiopoietin-2
10/07/2009	EP1385550B1 Therapeutic medicaments for inducing tolerance
10/07/2009	EP1339413B1 Compositions comprising complexes of phosphate derivatives of tocopherol
10/07/2009	EP1308441B1 2-aminopyridine compounds and use thereof as drugs
10/07/2009	EP1248774B1 Polyhydroxystilbenes and stilbene oxides as antipsoriatic agents and protein kinase inhibitors
10/07/2009	EP1105460B1 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof
10/07/2009	CN101553491A Quinoxaline derivative
10/07/2009	CN101553474A Imidazolone and imidazolidinone derivatives as 11b-HSD1 inhibitors for diabetes
10/07/2009	CN101553226A Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
10/07/2009	CN101550139A Dipeptidase-IV inhibitor containing v-triazolo [b] pyrazine
10/07/2009	CN101550125A Hazelnut element B, extracting method and pharmaceutical use thereof
10/07/2009	CN101550114A Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activity
10/07/2009	CN101550112A 4,5-disubstituted thiazole derivative, preparation method and use thereof
10/07/2009	CN101549149A New nasal spray formulation of calcitonin aqueous solution
10/07/2009	CN101549145A Nutrient fluid capable of being radio-resistant and reducing side reaction of radiation treatment
10/07/2009	CN101549132A New use of Chinese Traditional Medicine angelica, red peony root and rehmanniae radix for curing hyperlipidemia
10/07/2009	CN101549103A Dendrobium nobile polygonum multiflorum thunb capsules for auxiliary lipid-lowering and method for preparing the same
10/07/2009	CN101549096A Chinese medicine particles for treating diabetes
10/07/2009	CN101549092A Quality control method of toxicant elimination and fat cleanness tablet
10/07/2009	CN101549091A Health-care wine and uses thereof in diabetes acupuncture treatment
10/07/2009	CN101549064A Medicament composition containing chilopod acting on NEI network and uses thereof
10/07/2009	CN101549057A Chinese medicine composition for curing hyperlipemia, cerebral arteriosclerosis and ischemic apoplexy and method of preparing the same
10/07/2009	CN101549047A Five-element health-preserving capsule
10/07/2009	CN101549046A Health preserving product of north Chinese Caterpillar Fungus and glossy ganoderma
10/07/2009	CN101549045A Traditional Chinese medicine preparation for treating diabetes and preparation method thereof
10/07/2009	CN101549013A Capsule, tablet and granules of minium and preparation method
10/07/2009	CN101549008A Application of high-pressure continous extracted cassia seed extract in preparing hypolipemic medicine
10/07/2009	CN101548999A Preparation method and anti-obesic application of ginsenoside
10/07/2009	CN101548997A Application of medicament acting on NEI network for preparing medicine for curing vas pathological changes
10/07/2009	CN101548992A Method for preparing active polyphenol for strongly reducing blood fat
10/07/2009	CN101548989A Mactra veneriformis extract, preparation method and application thereof
10/07/2009	CN101548982A Application of dihydropyridazinone compounds in preparation of pharmaceutical for preventing and treating diabetes
10/07/2009	CN101548972A Solid pharmaceutical composition containing repaglinide
10/07/2009	CN101548967A Pharmaceutical composition
10/07/2009	CN101548961A Novel oral capsule preparation for curing diabetes mellitus and obesity
10/07/2009	CN101548757A Insoluble dietary fiber of raisin tree and preparing method thereof
10/07/2009	CN100547003C Antibodies to human IL-1 beta
10/07/2009	CN100546999C Bindwood sapogenin and its preparation method and use
10/07/2009	CN100546643C Method for preparing Chinese traditional medicine for treating upper warmer type diabetes
10/07/2009	CN100546626C Medicine for treating coronary heart disease, hyperlipidemia and senility resistance, and its preparation method
10/07/2009	CN100546622C A multi-element balanced health product
10/07/2009	CN100546583C Use of rhizoma anemarrhenae total saponin in preparation of medicine for treating hyperlipemia and arterial sclerosis
10/07/2009	CN100546582C Novel compound calcium replenishing tablet
10/07/2009	CN100546493C Fox fur nutrition enhancer
10/06/2009	US7598355 Characterization of GRP94-ligand interactions and purification, screening, and therapeutic methods relating thereto
10/06/2009	US7598293 Antidiabetic agents, antilipemic agents, dietetics, anticholesterol agents, hypotensive agents, cardiovascular disorders; (S)-Ethyl 2-methoxy-3-[4-{3-(4-methanesulfonyloxyphenyl) propylamino}phenyl]propionate
10/06/2009	US7598292 such as {2-Methyl-4-[2-(4-trifluoromethyl-phenoxymethyl )-allylsulfanyl]-phenoxy}-acetic acid, used as peroxisome proliferator-activated receptors modulators for treating or inhibit the progression of dyslipidemia
10/06/2009	US7598288 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
10/06/2009	US7598284 Indazole compounds as B3 adrenoceptor agonist
10/06/2009	US7598277 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine
10/06/2009	US7598272 Kinase inhibitors
10/06/2009	US7598271 Crystalline paroxetine methane sulfonate
10/06/2009	US7598266 Fused heterocyclic derivatives as PPAR modulators
10/06/2009	US7598262 Method for treating diabetes
10/06/2009	US7598253 Reverse-turn mimetics and methods relating thereto
10/06/2009	US7598247 Immunomodulating heterocyclic compounds
10/06/2009	US7598244 (S)-1-(3-ethoxy-1-methylpropyl)-3-[7-(3,4-methylenedioxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]urea; preventive and/or therapeutic agent for immunological rejection and/or graft versus host reaction in organ/bone marrow transplant, autoimmune disease, allergic disease and/or inflammatory disease
10/06/2009	US7598242 Compounds for the treatment of inflammatory disorders
10/06/2009	CA2427195C Controlled release metformin compositions
10/06/2009	CA2402431C 1,2,3,4-tetrahydroisoquinoline derivatives
10/06/2009	CA2400461C Method for improving bone modeling and chondrocyte functioning in growing canines
10/06/2009	CA2336469C Method of extracting antioxidants from labiate species and the extract products thereof
10/06/2009	CA2180479C Method for treatment of obesity using prolactin modulators and diet
10/06/2009	CA2120626C Method for enhancing gut absorption
10/06/2009	CA2111205C Polypeptides having kinase activity, their preparation and use
10/01/2009	WO2009120801A2 Ikki inhibitor therapies and screening methods, and related ikki diagnostics
10/01/2009	WO2009120760A1 Corin for treating obesity and diabetes
10/01/2009	WO2009120052A1 Pharmaceutical composition having a synergistic effect, for the treatment of high blood pressure and dyslipidemia
10/01/2009	WO2009119726A1 Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor
10/01/2009	WO2009119534A1 Novel tetrahydroisoquinoline derivative
10/01/2009	WO2009118968A1 Satiety sensation-inducing agent and food or drink containing the same
10/01/2009	WO2009118759A2 Heterocyclic compounds as adenosine receptor antagonist
10/01/2009	WO2009118473A2 Azetidine-derived compounds, preparation method therefor and therapeutic use of same
10/01/2009	WO2009118380A1 Use of oleuropein and derivatives in the treatment of type 2 diabetes mellitus and pathologies associated with protein aggregation phenomena
10/01/2009	WO2009100181A3 Absorbent ingestible agents and associated methods of manufacture and use
10/01/2009	WO2009080555A3 Carboxyl- or hydroxyl- substituted benzimidazole derivatives
10/01/2009	WO2009074300A3 Hedgehog pathway antagonists and therapeutic applications thereof
10/01/2009	WO2009065922A3 Organic compounds
10/01/2009	WO2009065919A3 Organic compounds
10/01/2009	WO2009056707A3 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof
10/01/2009	WO2009033809A3 Use of a peptide as a therapeutic agent
10/01/2009	WO2009033730A3 Peptide gxgrgdspca as a therapeutic agent
10/01/2009	WO2009033666A3 Use of parathyroid hormone ( 1-34 ) as anti-hiv agent
10/01/2009	US20090247636 Agent for suppression of gastric emptying comprising 4-hydroxyisoleucine
10/01/2009	US20090247626 Method of Treating Dyslipidemia Using Naturally Occurring Diterpene
10/01/2009	US20090247621 Diosmetin compounds, a process for their preparation and pharmaceutical composition containing them
10/01/2009	US20090247613 Chemically synthesized nucleic acid molecule with a pyrimidine modification; cancer, ocular disease, and other proliferative disorders; neovascularization, diabetic retinopathy, restenosis and polycystic kidney disease
10/01/2009	US20090247606 RNA Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
10/01/2009	US20090247589 Monocarboxylates for modifying macrophage function
10/01/2009	US20090247587 1,3-dihydroisobenzofuran derivatives
10/01/2009	US20090247560 Diaryl ketimine derivative
10/01/2009	US20090247557 Partial and full agonists of a1 adenosine receptors
10/01/2009	US20090247556 Azolopyrimidines as Inhibitors of Cannabinoid 1 Activity
10/01/2009	US20090247550 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as hdl-cholesterol raising agents
10/01/2009	US20090247534 New compounds
10/01/2009	US20090247528 Method of treating attention deficit disorder

1 ... 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 ... 1298